Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer

Genome-Wide Gene Expression Profile Analyses Identify CTTN as a Potential Prognostic Marker in Esophageal Cancer

(2014) Pei Lu et al.   PLoS One

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways

(2013) Si Gao et al.   CANCER LETTERS

miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition

(2013) Chaoyang Sun et al.   JNCI-Journal of the National Cancer Institute

Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells

(2011) Davide Staedler et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines

(2008) Adrián M. Ramos et al.   BIOCHEMICAL PHARMACOLOGY

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

(2008) M. L. Heaney et al.   CANCER RESEARCH

Flavonoid intake and ovarian cancer risk in a population-based case-control study

(2008) Margaret A. Gates et al.   INTERNATIONAL JOURNAL OF CANCER

Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPSdown-regulation

(2008) Jin Yeop Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY